A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis
暂无分享,去创建一个
Gianmario Sambuceti | Michele Piana | Annalisa Perasso | Cristina Campi | Anna Maria Massone | Mauro C. Beltrametti | Adriano Chiò | Angelina Cistaro | Cecilia Marini | Cristina Moglia | Andrea Calvo | Claudia Caponnetto | Silvia Morbelli | Ambra Buschiazzo | Paolo Bruzzi | C. Campi | A. Chiò | M. Piana | F. Nobili | P. Bruzzi | A. Calvo | G. Mancardi | S. Morbelli | G. Sambuceti | C. Moglia | A. Massone | A. Canosa | C. Caponnetto | S. Cammarosano | A. Buschiazzo | C. Marini | C. Scialò | P. Fania | A. Cistaro | Antonio Canosa | Piercarlo Fania | Flavio Mariano Nobili | E. Pomposelli | G. Novi | Gianluigi Mancardi | Giovanni Novi | Carlo Scialò | Elena Pomposelli | Maria Caludia Bagnara | Stefania Cammarosano | M. Beltrametti | A. Perasso | M. Bagnara | Annalisa Perasso
[1] Annalisa Perasso,et al. Spinal Canal and Spinal Marrow Segmentation by Means of the Hough Transform of Special Classes of Curves , 2015, ICIAP.
[2] Bruce R. Rosen,et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28 , 2015, NeuroImage: Clinical.
[3] D. Troost,et al. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis , 1990, Neuropathology and applied neurobiology.
[4] John F. Canny,et al. A Computational Approach to Edge Detection , 1986, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[5] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[6] David E. Elder. Thin melanoma. , 2011, Archives of pathology & laboratory medicine.
[7] Michael Schuetz,et al. Diagnosis and Prognosis of Traumatic Spinal Cord Injury , 2011, Global spine journal.
[8] P. Kushner,et al. Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis , 1990, Annals of neurology.
[9] P. Mcgeer,et al. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. , 1992, The American journal of pathology.
[10] P. Sham,et al. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis , 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[11] Jonathan M. Bekisz,et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[12] D. Brooks,et al. Cortical involvement in four cases of primary lateral sclerosis using [11C]-flumazenil PET , 2007, Journal of Neurology.
[13] J. Thie. Understanding the standardized uptake value, its methods, and implications for usage. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[15] A. Al-Chalabi,et al. Prolonged survival in motor neuron disease: a descriptive study of the King’s database 1990–2002 , 2003, Journal of neurology, neurosurgery, and psychiatry.
[16] Adriano Chiò,et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis , 2014, Neurology.
[17] A. Chiò,et al. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[18] Annalisa Perasso,et al. Profile Detection in Medical and Astronomical Images by Means of the Hough Transform of Special Classes of Curves , 2014, Journal of Mathematical Imaging and Vision.
[19] C. Zuo,et al. MRI and FDG PET/CT findings in 3 cases of spinal infectious arachnoiditis. , 2014, Clinical nuclear medicine.
[20] A. Chiò,et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[21] P. Mccombe,et al. The Role of Immune and Inflammatory Mechanisms in ALS , 2011, Current molecular medicine.
[22] Caroline Prunier,et al. Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis , 2012, PloS one.
[23] A. Kengne,et al. Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review , 2014, BMC Research Notes.
[24] W. Robberecht,et al. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease , 2011, The Lancet Neurology.
[25] Y. Naparstek,et al. Wegener granulomatosis with back pain, periaortitis, and dural inflammation developing while receiving monthly cyclophosphamide. , 2006, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[26] C. Trampal,et al. 18F-FDG PET detection of spinal leptomeningeal metastases from cerebral glioblastoma multiforme , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[27] J. Trojanowski,et al. Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis , 2012, PloS one.
[28] J. Cedarbaum,et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.
[29] C. Campi,et al. Allogeneic cell transplant expands bone marrow distribution by colonizing previously abandoned areas: an FDG PET/CT analysis. , 2015, Blood.
[30] C. Campi,et al. Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alteration. , 2014, Radiology.
[31] Michele Piana,et al. Hough Transform of Special Classes of Curves , 2013, SIAM J. Imaging Sci..
[32] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[33] C. Campi,et al. Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT imaging , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[34] M. Filippi,et al. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes , 2014, The Lancet Neurology.
[35] M Ariet,et al. Determination of ideal body weight for drug dosage calculations. , 1983, American journal of hospital pharmacy.